Albert Boehringer
Source of wealth: Pharmaceuticals
...
...
Modules
Biography
Albert Boehringer derives his fortune from Boehringer Ingelheim, the world's largest privately-held pharmaceutical company founded by his grandfather with just 28 employees.
Founded in 1885 in Ingelheim am Rhein, Germany (and still headquartered there), its entrepreneurial roots date as far back to 1817.
The company employs 53,000 people worldwide and has a presence in 130 markets.
Some of its most well-known drugs include those that treat COPD, anti-coagulation and type 2 diabetes.
Albert along with 14 members of the family own equal parts of the company; they are part of the third, fourth or fifth generation.
Financial Assets
Financial assets information not available.
The Great Lie of Mega-Fortunes: The Case of Albert Boehringer
Billionaires are often presented under the romantic myth of the 'self-made person': a narrative designed to justify opulence as the natural reward for hard work, effort, or ingenuity. However, when confronting such extreme volumes of wealth with macroeconomic reality, the meritocracy narrative completely breaks down. No individual can legitimately generate through personal effort a fortune equivalent to millions of times the average working-class salary. Capital at the top does not grow because of exceptional talent; it expands through an implacable dynamic where accumulated money works exponentially faster than people, devouring the wealth generated by productive labor.
The immense fortune of Albert Boehringer, linked to Healthcare and 'Pharmaceuticals', has not been built in a free-market vacuum, but through rent-seeking, the use of exclusive elite influence, the consolidation of monopoly positions, or inherited wealth. Far from taking real private risks, billionaire empires structurally depend on state support through direct subsidies, infrastructure use, exploitation of R&D, public contracts, and offshore tax engineering. While this wealth is equivalent to the physical weight of 46 tons of pure gold, the rest of the planet suffers from an artificial scarcity of basic resources. The fact that this wealth is enough to fully fund the public health system of DR Congo, a country with more than 105800000 million inhabitants for 2.9 years, proves that unlimited accumulation is not an entrepreneurial achievement, but the hijacking of democratic sovereignty.